Structure−Activity Relationships and Pharmacokinetic Analysis for a Series of Potent, Systemically Available Biphenylsulfonamide Matrix Metalloproteinase Inhibitors
- 1 January 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (2), 156-166
- https://doi.org/10.1021/jm9903141
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- X‐ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivityProtein Science, 1999
- Role of His-224 in the Anomalous pH Dependence of Human Stromelysin-1Biochemistry, 1998
- Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid DerivativesJournal of Medicinal Chemistry, 1998
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997
- Discovering High-Affinity Ligands for Proteins: SAR by NMRScience, 1996
- AMoRe: an automated package for molecular replacementActa Crystallographica Section A Foundations of Crystallography, 1994
- Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functionsPharmacology & Therapeutics, 1993
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Gene Expression (Collagenase, Tissue Inhibitor of Metalloproteinases, Complement, and HLA–DR) in Rheumatoid Arthritis and Osteoarthritis Synovium. Quantitative Analysis and Effect of Intraarticular CorticosteroidsArthritis & Rheumatism, 1991
- Thunderstorms: An Important Mechanism in the Transport of Air PollutantsScience, 1987